Charts Adaptive Biotechnologies Corporation
Stocks
ADPT
US00650F1093
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
00:00:00 05/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 24.28 USD | -1.18% |
|
-3.61% | +49.51% |
| 08-20 | Adaptive Biotechnologies Insider Sold Shares Worth $3,135,850, According to a Recent SEC Filing | MT |
| 07-30 | Adaptive Biotechnologies Q2 Loss Widens, Revenue Rise | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ADPT | Delayed | |
CBOE
| ADPT | Real-time | |
Tradegate
| 1HM | Real-time | |
Boerse Muenchen
| 1HM | Real-time | |
Deutsche Boerse AG
| 1HM | Delayed | |
Börse Stuttgart
| 1HM | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 26.44 | 26.44 | 25.99 |
| Spread/Res. | -8.17% | -8.17% | -6.58% |
| Spread/Supp. | +7.82% | +29.63% | +37.95% |
| Support | 22.52 | 18.73 | 17.6 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ADPT Stock
- Charts Adaptive Biotechnologies Corporation
Select your edition
All financial news and data tailored to specific country editions

















